NM_000388.4(CASR):c.2316C>T (p.Ala772=) AND Nephrolithiasis/nephrocalcinosis
- Germline classification:
- Likely benign (1 submission)
- Last evaluated:
- Jun 21, 2019
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV004030373.1
Allele description [Variation Report for NM_000388.4(CASR):c.2316C>T (p.Ala772=)]
NM_000388.4(CASR):c.2316C>T (p.Ala772=)
Condition(s)
- Name:
- Nephrolithiasis/nephrocalcinosis
- Identifiers:
- MedGen: CN580796
-
3I.2-hydroxysteroid dehydrogenase [Acanthopagrus latus]
3I.2-hydroxysteroid dehydrogenase [Acanthopagrus latus]gi|2642094913|gb|WQY91213.1|Protein
-
myocyte-specific enhancer binding factor 2B [Acanthopagrus latus]
myocyte-specific enhancer binding factor 2B [Acanthopagrus latus]gi|2714719648|gb|WZB34446.1|Protein
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Nov 3, 2024